It was also shown in in vitro studies that the addition of purified exogenous IFNs after rotavirus infection of human IECs does not significantly hamper viral replication; however, IFN treatment of cells prior to viral challenge is required to achieve an efficient restriction of rotavirus replication (32). The gene discussed is IFNA1; the disease is Rotavirus infection.